ID   LIPA3_HUMAN             Reviewed;        1194 AA.
AC   O75145; A8K142; Q3MJA0; Q9H8B5; Q9UEW4;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-FEB-2004, sequence version 3.
DT   28-JUN-2023, entry version 187.
DE   RecName: Full=Liprin-alpha-3;
DE   AltName: Full=Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3;
DE            Short=PTPRF-interacting protein alpha-3;
GN   Name=PPFIA3; Synonyms=KIAA0654;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 152-1194 (ISOFORM 2), AND VARIANT SER-563.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT SER-563.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 909-1194 (ISOFORM 2), AND VARIANT SER-563.
RC   TISSUE=Brain, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 752-1194 (ISOFORM 1), TISSUE SPECIFICITY,
RP   FUNCTION, INTERACTION WITH PTPRD; PTPRF AND PTPRS, OLIGOMERIZATION, AND
RP   DOMAIN.
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-207 AND THR-714, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=23124857; DOI=10.1007/s00418-012-1044-y;
RA   Joshi C.S., Suryawanshi A.R., Khan S.A., Balasinor N.H., Khole V.V.;
RT   "Liprin alpha3: a putative estrogen regulated acrosomal protein.";
RL   Histochem. Cell Biol. 139:535-548(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17; SER-142; SER-683; THR-714
RP   AND SER-1164, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: May regulate the disassembly of focal adhesions. May localize
CC       receptor-like tyrosine phosphatases type 2A at specific sites on the
CC       plasma membrane, possibly regulating their interaction with the
CC       extracellular environment and their association with substrates.
CC       {ECO:0000269|PubMed:9624153}.
CC   -!- SUBUNIT: Forms homodimers and heterodimers with liprins-alpha and
CC       liprins-beta (PubMed:9624153). Interacts with the second PTPase domain
CC       of PTPRD, PTPRF and PTPRS (PubMed:9624153). Binds RIMS1, RIMS2, RIMS3
CC       and RIMS4 (By similarity). {ECO:0000250|UniProtKB:Q91Z79,
CC       ECO:0000269|PubMed:9624153}.
CC   -!- INTERACTION:
CC       O75145; Q8NA61-2: CBY2; NbExp=3; IntAct=EBI-1763225, EBI-11524851;
CC       O75145; Q9NRI5-2: DISC1; NbExp=3; IntAct=EBI-1763225, EBI-11988027;
CC       O75145; Q96KQ4: PPP1R13B; NbExp=3; IntAct=EBI-1763225, EBI-1105153;
CC       O75145; O60504: SORBS3; NbExp=3; IntAct=EBI-1763225, EBI-741237;
CC       O75145; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-1763225, EBI-1105213;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q91Z79}.
CC       Cytoplasmic vesicle, secretory vesicle, acrosome
CC       {ECO:0000269|PubMed:23124857}. Note=Also detected in epididymosome.
CC       {ECO:0000250|UniProtKB:Q91Z79}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O75145-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O75145-2; Sequence=VSP_009392;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain (PubMed:9624153).
CC       Also detected in sperm (at protein level) (PubMed:23124857).
CC       {ECO:0000269|PubMed:23124857, ECO:0000269|PubMed:9624153}.
CC   -!- DOMAIN: The N-terminal coiled coil regions mediate homodimerization
CC       preferentially and heterodimerization type alpha/alpha. The C-terminal,
CC       non-coiled coil regions mediate heterodimerization type alpha/beta and
CC       interaction with PTPRD, PTPRF and PTPRS. {ECO:0000269|PubMed:9624153}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be due to exon skipping. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the liprin family. Liprin-alpha subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31629.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB014554; BAA31629.2; ALT_INIT; mRNA.
DR   EMBL; AK023850; BAB14702.1; -; mRNA.
DR   EMBL; AK025972; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK289757; BAF82446.1; -; mRNA.
DR   EMBL; CH471177; EAW52457.1; -; Genomic_DNA.
DR   EMBL; BC021255; AAH21255.2; -; mRNA.
DR   EMBL; BC101518; AAI01519.1; -; mRNA.
DR   EMBL; BC101520; AAI01521.1; -; mRNA.
DR   EMBL; AF034800; AAC26101.1; -; mRNA.
DR   CCDS; CCDS12758.1; -. [O75145-1]
DR   RefSeq; NP_003651.1; NM_003660.3. [O75145-1]
DR   RefSeq; XP_016882896.1; XM_017027407.1. [O75145-2]
DR   AlphaFoldDB; O75145; -.
DR   SMR; O75145; -.
DR   BioGRID; 114111; 40.
DR   IntAct; O75145; 14.
DR   MINT; O75145; -.
DR   STRING; 9606.ENSP00000335614; -.
DR   GlyGen; O75145; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75145; -.
DR   PhosphoSitePlus; O75145; -.
DR   BioMuta; PPFIA3; -.
DR   EPD; O75145; -.
DR   jPOST; O75145; -.
DR   MassIVE; O75145; -.
DR   MaxQB; O75145; -.
DR   PaxDb; O75145; -.
DR   PeptideAtlas; O75145; -.
DR   ProteomicsDB; 49808; -. [O75145-1]
DR   ProteomicsDB; 49809; -. [O75145-2]
DR   Antibodypedia; 31915; 87 antibodies from 23 providers.
DR   DNASU; 8541; -.
DR   Ensembl; ENST00000334186.9; ENSP00000335614.3; ENSG00000177380.14. [O75145-1]
DR   Ensembl; ENST00000602351.5; ENSP00000473622.1; ENSG00000177380.14. [O75145-2]
DR   GeneID; 8541; -.
DR   KEGG; hsa:8541; -.
DR   MANE-Select; ENST00000334186.9; ENSP00000335614.3; NM_003660.4; NP_003651.1.
DR   UCSC; uc002pmr.5; human. [O75145-1]
DR   AGR; HGNC:9247; -.
DR   CTD; 8541; -.
DR   DisGeNET; 8541; -.
DR   GeneCards; PPFIA3; -.
DR   HGNC; HGNC:9247; PPFIA3.
DR   HPA; ENSG00000177380; Tissue enhanced (brain, pituitary gland, skin).
DR   MIM; 603144; gene.
DR   neXtProt; NX_O75145; -.
DR   OpenTargets; ENSG00000177380; -.
DR   PharmGKB; PA33568; -.
DR   VEuPathDB; HostDB:ENSG00000177380; -.
DR   eggNOG; KOG0249; Eukaryota.
DR   GeneTree; ENSGT01050000244900; -.
DR   HOGENOM; CLU_006923_0_0_1; -.
DR   InParanoid; O75145; -.
DR   OMA; VAALNKX; -.
DR   OrthoDB; 2906732at2759; -.
DR   PhylomeDB; O75145; -.
DR   TreeFam; TF314207; -.
DR   PathwayCommons; O75145; -.
DR   Reactome; R-HSA-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   SignaLink; O75145; -.
DR   BioGRID-ORCS; 8541; 14 hits in 1157 CRISPR screens.
DR   ChiTaRS; PPFIA3; human.
DR   GenomeRNAi; 8541; -.
DR   Pharos; O75145; Tbio.
DR   PRO; PR:O75145; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; O75145; protein.
DR   Bgee; ENSG00000177380; Expressed in right hemisphere of cerebellum and 122 other tissues.
DR   ExpressionAtlas; O75145; baseline and differential.
DR   Genevisible; O75145; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0098875; C:epididymosome; ISS:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0048786; C:presynaptic active zone; IBA:GO_Central.
DR   GO; GO:0098831; C:presynaptic active zone cytoplasmic component; IEA:Ensembl.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0048172; P:regulation of short-term neuronal synaptic plasticity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0050808; P:synapse organization; IBA:GO_Central.
DR   GO; GO:0016081; P:synaptic vesicle docking; IEA:Ensembl.
DR   CDD; cd09562; SAM_liprin-alpha1_2_3_4_repeat1; 1.
DR   CDD; cd09565; SAM_liprin-alpha1_2_3_4_repeat2; 1.
DR   CDD; cd09568; SAM_liprin-alpha1_2_3_4_repeat3; 1.
DR   Gene3D; 1.10.287.1490; -; 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 3.
DR   InterPro; IPR029515; Liprin.
DR   InterPro; IPR037620; Liprin-alpha_SAM_rpt_1.
DR   InterPro; IPR037621; Liprin-alpha_SAM_rpt_2.
DR   InterPro; IPR037622; Liprin-alpha_SAM_rpt_3.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR12587; LAR INTERACTING PROTEIN LIP -RELATED PROTEIN; 1.
DR   PANTHER; PTHR12587:SF4; LIPRIN-ALPHA-3; 1.
DR   Pfam; PF00536; SAM_1; 2.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00454; SAM; 3.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 3.
DR   PROSITE; PS50105; SAM_DOMAIN; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   Phosphoprotein; Reference proteome; Repeat.
FT   CHAIN           1..1194
FT                   /note="Liprin-alpha-3"
FT                   /id="PRO_0000191029"
FT   DOMAIN          838..904
FT                   /note="SAM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          953..1017
FT                   /note="SAM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          1041..1110
FT                   /note="SAM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          202..233
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          525..583
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          624..819
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1157..1194
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          26..133
FT                   /evidence="ECO:0000255"
FT   COILED          161..501
FT                   /evidence="ECO:0000255"
FT   COILED          596..644
FT                   /evidence="ECO:0000255"
FT   COILED          1014..1040
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        544..558
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        638..673
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1174..1194
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         431
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13136"
FT   MOD_RES         508
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P60469"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13136"
FT   MOD_RES         645
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P60469"
FT   MOD_RES         668
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13136"
FT   MOD_RES         683
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         714
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         737
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13136"
FT   MOD_RES         792
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z79"
FT   MOD_RES         794
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z79"
FT   MOD_RES         1123
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13136"
FT   MOD_RES         1164
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         937..945
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009392"
FT   VARIANT         563
FT                   /note="A -> S (in dbSNP:rs2303053)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|Ref.4"
FT                   /id="VAR_017757"
FT   CONFLICT        878
FT                   /note="E -> K (in Ref. 6; AAC26101)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1011
FT                   /note="I -> V (in Ref. 6; AAC26101)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1194 AA;  133496 MW;  4DD92531AD8AE12D CRC64;
     MMCEVMPTIS EDGRRGSALG PDEAGGELER LMVTMLTERE RLLETLREAQ DGLATAQLRL
     RELGHEKDSL QRQLSIALPQ EFAALTKELN LCREQLLERE EEIAELKAER NNTRLLLEHL
     ECLVSRHERS LRMTVVKRQA QSPGGVSSEV EVLKALKSLF EHHKALDEKV RERLRMALER
     VAVLEEELEL SNQETLNLRE QLSRRRSGLE EPGKDGDGQT LANGLGPGGD SNRRTAELEE
     ALERQRAEVC QLRERLAVLC RQMSQLEEEL GTAHRELGKA EEANSKLQRD LKEALAQRED
     MEERITTLEK RYLSAQREAT SLHDANDKLE NELASKESLY RQSEEKSRQL AEWLDDAKQK
     LQQTLQKAET LPEIEAQLAQ RVAALNKAEE RHGNFEERLR QLEAQLEEKN QELQRARQRE
     KMNDDHNKRL SETVDKLLSE SNERLQLHLK ERMGALEEKN SLSEEIANMK KLQDELLLNK
     EQLLAEMERM QMEIDQLRGR PPSSYSRSLP GSALELRYSQ APTLPSGAHL DPYVAGSGRA
     GKRGRWSGVK EEPSKDWERS APAGSIPPPF PGELDGSDEE EAEGMFGAEL LSPSGQADVQ
     TLAIMLQEQL EAINKEIKLI QEEKETTEQR AEELESRVSS SGLDSLGRYR SSCSLPPSLT
     TSTLASPSPP SSGHSTPRLA PPSPAREGTD KANHVPKEEA GAPRGEGPAI PGDTPPPTPR
     SARLERMTQA LALQAGSLED GGPPRGSEGT PDSLHKAPKK KSIKSSIGRL FGKKEKGRMG
     PPGRDSSSLA GTPSDETLAT DPLGLAKLTG PGDKDRRNKR KHELLEEACR QGLPFAAWDG
     PTVVSWLELW VGMPAWYVAA CRANVKSGAI MANLSDTEIQ REIGISNPLH RLKLRLAIQE
     MVSLTSPSAP ASSRTSTGNV WMTHEEMESL TATTKPETKE ISWEQILAYG DMNHEWVGND
     WLPSLGLPQY RSYFMESLVD ARMLDHLNKK ELRGQLKMVD SFHRVSLHYG IMCLKRLNYD
     RKDLERRREE SQTQIRDVMV WSNERVMGWV SGLGLKEFAT NLTESGVHGA LLALDETFDY
     SDLALLLQIP TQNAQARQLL EKEFSNLISL GTDRRLDEDS AKSFSRSPSW RKMFREKDLR
     GVTPDSAEML PPNFRSAAAG ALGSPGLPLR KLQPEGQTSG SSRADGVSVR TYSC
//
